Zhao et al. revealed that miR-3142 regulated cell proliferation and chemoresistance through activating the PTEN/AKT pathway in CML (Zhao et al., 2017). Here, AKT1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.